Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Jörg Kotzerke, Dresden University of Technology
ClinicalTrials.gov Identifier:
NCT00180154
First received: September 13, 2005
Last updated: August 23, 2011
Last verified: August 2011
  Purpose

The purpose of the study is to describe the regional and global FDG-kinetics in non-small-cell lung cancer (NSCLC) during percutaneous radiation therapy.


Condition
Lung Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Tumor Metabolism of Lung Cancer Underwent Percutaneous Radiation Measured With F-18-FDG-PET

Resource links provided by NLM:


Further study details as provided by Technische Universität Dresden:

Estimated Enrollment: 50
Study Start Date: July 2005
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

The study includes consecutive patients from Department of Radiooncology with inoperable non-small cell lung cancer (NSCLC) intended for a curative radiotherapy.

Criteria

Inclusion Criteria:

  • Histologically confirmed NSCLC not curable by surgery
  • Karnofsky > 80%
  • Tumor volume and localization allow curative radiotherapy
  • Written consent

Exclusion Criteria:

  • Metastases
  • Diabetes
  • Pregnancy
  • Psychiatric impairment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00180154

Locations
Germany
Department of Nuclear Medicine
Dresden, Germany, 01307
Sponsors and Collaborators
Technische Universität Dresden
Investigators
Principal Investigator: Joerg Kotzerke, MD Department of Nuclear Medicine
  More Information

No publications provided

Responsible Party: Jörg Kotzerke, Prof. Dr., Dresden University of Technology
ClinicalTrials.gov Identifier: NCT00180154     History of Changes
Other Study ID Numbers: BCA-FDG-FU
Study First Received: September 13, 2005
Last Updated: August 23, 2011
Health Authority: Germany: Federal Office for Radiation Protection

Keywords provided by Technische Universität Dresden:
radiation therapy
F-18-FDG
NSCLC

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on August 26, 2014